scholarly article | Q13442814 |
P356 | DOI | 10.1212/01.WNL.0000341274.61236.02 |
P698 | PubMed publication ID | 19171827 |
P50 | author | Grete Andersen | Q54156230 |
P2093 | author name string | J Vissing | |
C Crone | |||
N Preisler | |||
F Wibrand | |||
T D Jeppesen | |||
F Thøgersen | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | muscular atrophy | Q2844600 |
P304 | page(s) | 317-323 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease). | |
P478 | volume | 72 |
Q35935094 | A randomized controlled trial of exercise in spinal and bulbar muscular atrophy |
Q35890267 | Aerobic Training in Patients with Congenital Myopathy |
Q38634370 | Clinical Trials in Spinal and Bulbar Muscular Atrophy-Past, Present, and Future |
Q34622281 | Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial |
Q38639343 | Exercise Therapy in Spinobulbar Muscular Atrophy and Other Neuromuscular Disorders. |
Q38108541 | Exercise in neuromuscular disease |
Q92863877 | Exercise therapy for muscle and lower motor neuron diseases |
Q90026120 | High-intensity training in patients with spinal and bulbar muscular atrophy |
Q39968447 | Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice |
Q38597312 | Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease). |
Q64082911 | Muscle contractility in spinobulbar muscular atrophy |
Q37899974 | Neurotoxic effects of androgens in spinal and bulbar muscular atrophy. |
Q34637225 | Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). |
Q27007098 | Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy |
Q38246221 | Potential therapeutic targets in polyglutamine-mediated diseases |
Q58564785 | Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial |
Q42002252 | Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative? |
Q34499899 | Spinal and Bulbar Muscular Atrophy. |
Q30612908 | Spinal and bulbar muscular atrophy: pathogenesis and clinical management |
Q91813426 | The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations |
Q64085965 | The effect of two different aerobic training modalities in a child with spinal muscular atrophy type II: a case report |
Q33701169 | Therapeutic approaches to spinal and bulbar muscular atrophy |
Q48015086 | Training improves oxidative capacity, but not function, in spinal muscular atrophy type III. |
Q37572139 | Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy |
Search more.